Corbus Pharmaceuticals Holdings Inc (CRBP) stock is down -72.22% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives CRBP stock a score of 14 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 9. CRBP's rank also includes a long-term technical score of 13. The fundamental score for CRBP is 21. In addition to the average rating from Wall Street analysts, CRBP stock has a mean target price of 1.84. This means analysts expect the stock to fall 0.54% over the next 12 months.
What's Happening with CRBP Stock Today
Corbus Pharmaceuticals Holdings Inc (CRBP) stock has fallen -5.18% while the S&P 500 has gained 1.94% as of 1:27 PM on Thursday, Jan 28. CRBP is down -$0.10 from the previous closing price of $1.95 on volume of 7,085,743 shares. Over the past year the S&P 500 is higher by 16.81% while CRBP is down -72.22%. CRBP lost -$1.78 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Corbus Pharmaceuticals Holdings Inc (CRBP) Stock.
